title: Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
authors.affiliation: Columbia University College of Physicians and Surgeons, New York, NY 10032.
authors.forename: A I
authors.initials: AI
authors.lastname: Benvenisty
authors.forename: G A
authors.initials: GA
authors.lastname: Tannenbaum
authors.forename: D J
authors.initials: DJ
authors.lastname: Cohen
authors.forename: G
authors.initials: G
authors.lastname: Appel
authors.forename: M A
authors.initials: MA
authors.lastname: Hardy
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D004351:Drug Resistance; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011241:Prednisone; D008775:Methylprednisolone